Daniel Richman Email & Phone Number
Director, Early Assets and Clinical Development @ Boehringer Ingelheim
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Daniel Richman Location
- New York, NY, US
Daniel Richman Work
- 2025 -now Director, Early Assets and Clinical Development @
- 2023 -2025 Clinical Development Strategy Director @
- 2023 -2023 Clinical Development and Medical Affairs Director , Immunology @
- 2022 -2023 Clinical Development and Medical Affairs Strategy Director @
- 2019 -2021 Global Medical Director Immuno-Dermatology (LifecycleManagement) @
- 2018 -2019 SeniorMedical Affairs Manager for Immunology and Dermatology @
- 2016 -2018 Medical Manager for Oncology-Hematology and Rare Diseases and Endocrinology Franchises @
- 2015 -2016 Medical Affairs Manager Uro-Oncology @
- 2014 -2015 InternationalMedical AffairsManager and Business Development Strategy @
- 2013 -2014 Medical Affairs Trainee and Health Economics Supervisor -Oncology @
Daniel Richman Education
- King's College London 2020-2022
- Harvard Medical School
(Genetics)
- Faculdades Souza Marques
Doctor of Medicine (Medicine)
Daniel Richman Summary
- Daniel Richman, based in New York, NY, US, is currently a Director, Early Assets and Clinical Development at Boehringer Ingelheim. Daniel Richman brings experience from previous roles at Boehringer Ingelheim, Vaniam Group and Sanofi. Daniel Richman holds a 2020 - 2022 King's College London. Daniel Richman has 5 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Daniel Richman?
Find contact details for 700 million professionals.
Others Named Daniel Richman
Daniel Richman
Managing Partner
New York, United States
Daniel Richman
Content Supply Chain Consultant
Salt Lake City, UT, US
Daniel Richman
Founder
Amsterdam, NH, NL
Daniel Richman
Director, Early Assets and Clinical Development
New York, NY, US
Daniel Richman
Sales Representative
Montreal, QC, CA
Daniel Richman
Customer Service Manager
Ponder, TX, US
Top Boehringer Ingelheim Employees
Shashank Deshpande
Chairman of the Board of Managing Directors and Head of Human Pharma
Ingelheim am Rhein, RP, DE
Torsten Koch
Vice President, Head of GBS Process and Program Management
Stadecken-Elsheim, RP, DE
Christoph Ruland
VP, General Manager, Human Pharma Germany
Ingelheim am Rhein, RP, DE
Mario Riesner
Head Global Operations HP (EVP)
Ingelheim am Rhein, RP, DE
Max Schrecklinger
CFO Human Pharma Business Unit
Ingelheim am Rhein, RP, DE
Kerstin Walke
VP Analytical Development Biologicals
Ingelheim am Rhein, RP, DE
Clemens Twardy
Corporate Vice President, Head of Global Supply Chain and Lifecycle Management Animal Health
Ingelheim am Rhein, RP, DE
Lutz Hampe
CRO Monitor Analytical Development Biologics
Warthausen, BW, DE
Markus Schümmelfeder
CIO
Bavaria, Germany
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co